Ernexa Therapeutics (ERNA) Assets (2010 - 2026)
Ernexa Therapeutics (ERNA) reported Assets of $6.32 million for Q2 2026, down 16.7% from $7.58 million a year earlier and down 40.1% from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Ernexa Therapeutics posted Assets of $5.83 million, up 10.7% from FY2024.
- Assets has a five-year compound annual growth rate of -14.7% (FY2020 to FY2025).
- By year, Assets came in at $5.27 million in FY2024 (-89.3%), $49.13 million in FY2023 (+120.5%), $22.28 million in FY2022 (-29.3%) and $31.53 million in FY2021 (+144.3%).
- Five-year quarterly Assets spans a low of $5.06 million in Q1 2025 and a high of $52.25 million in Q3 2023.
- Year over year, Assets gained in two of the last eight quarters, with an average decline of 33.2%.
- The high point for year-over-year Assets in five years was Q3 2021 (growth of 679.5%); the low point was Q1 2025 (a decline of 89.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $10.54 million (Q1 2026), $5.83 million (Q4 2025) and $6.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Ernexa Therapeutics | 2.45 Mn | -16.70 Mn | - | 6.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.32 Mn |
| Mar 31, 2026 | 10.54 Mn |
| Dec 31, 2025 | 5.83 Mn |
| Sep 30, 2025 | 6.17 Mn |
| Jun 30, 2025 | 7.58 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 5.27 Mn |
| Sep 30, 2024 | 7.72 Mn |
| Jun 30, 2024 | 46.49 Mn |
| Mar 31, 2024 | 49.66 Mn |
| Dec 31, 2023 | 49.13 Mn |
| Sep 30, 2023 | 52.25 Mn |
| Jun 30, 2023 | 46.95 Mn |
| Mar 31, 2023 | 15.11 Mn |
| Dec 31, 2022 | 22.28 Mn |
| Sep 30, 2022 | 20.93 Mn |
| Jun 30, 2022 | 26.90 Mn |
| Mar 31, 2022 | 35.38 Mn |
| Dec 31, 2021 | 31.53 Mn |
| Sep 30, 2021 | 39.39 Mn |
API Access
Ernexa Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();